Recombinant Sulfolobus islandicus rod-shaped virus 1 Uncharacterized protein 84 (84)

Shipped with Ice Packs
In Stock

Description

Interaction Partners and Functional Hypotheses

ORF84a interacts homotypically in yeast two-hybrid assays, forming self-oligomers . This property is shared with other SIRV2 proteins, such as ORF103a and ORF131a, which are implicated in viral capsid assembly or genome packaging . While ORF84a’s exact function remains unclear, its interaction profile suggests involvement in:

  • Viral Genome Replication: Homotypic interactions may facilitate DNA condensation or replication fork resolution.

  • Host Defense Evasion: Similar to SIRV2’s Holliday junction resolvase (ORF121), which interacts with host PCNA3 to disrupt DNA repair pathways , ORF84a might modulate host machinery.

Host Response to SIRV Infection

During SIRV2 infection, host genes involved in cell division (e.g., cdv operon) and toxin-antitoxin systems are downregulated, while mobile elements (e.g., insertion sequences) are upregulated . While ORF84a is not explicitly linked to these pathways, its homotypic behavior aligns with viral strategies to hijack host processes.

Host ResponseFunctional Impact
Cell Division Machinerycdv operon downregulated (10-fold), delaying host cell division
Toxin-Antitoxin Systems11/16 VapBC and 3/6 HEP-NT loci upregulated, balancing survival and stress
Insertion SequencesIS1048 group (IS630 family) highly expressed, enabling genome instability

Comparative Analysis with SIRV2 Proteins

SIRV2 encodes proteins with defined roles, such as:

  • ORF121: Holliday junction resolvase (interacts with SIRV2 virion coat protein gp26) .

  • ORF83a/b: DNA-binding proteins interacting with Holliday junction resolvase .

  • ORF335/356: Glycosyltransferases involved in capsid modification .

ORF84a lacks these annotations but shares homotypic interaction characteristics with SIRV2 proteins like ORF103a and ORF131a . This suggests a conserved mechanism for viral protein self-assembly, potentially critical for capsid formation or viral genome organization.

Research Gaps and Future Directions

ORF84a remains poorly characterized due to:

  1. Lack of Functional Studies: No enzymatic assays or knockout mutants exist.

  2. Structural Ambiguity: No crystallographic or cryo-EM data are available.

  3. Host Interaction Data: No direct evidence of ORF84a binding to host proteins.

Future research should prioritize:

  • Co-IP/MS Experiments: Identify host or viral interaction partners.

  • Structural Modeling: Predict secondary/tertiary structure using homologs (e.g., SIRV2 ORF121).

  • Mutagenesis Studies: Assess ORF84a’s role in viral replication or host range.

Recombinant Expression and Applications

While recombinant ORF84a has not been explicitly reported, methods developed for SIRV2 proteins (e.g., S. solfataricus expression systems ) could enable its production. Potential applications include:

  • Antiviral Target Development: Blocking homotypic interactions may disrupt viral assembly.

  • Biotechnological Tools: Leveraging its DNA-binding properties for archaeal genetic engineering.

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have a specific format requirement, please indicate it when placing your order. We will fulfill your request accordingly.
Lead Time
Delivery time may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery time estimates.
Note: All of our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please notify us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging this vial prior to opening to ensure the contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard final concentration of glycerol is 50%. Customers can use this as a reference.
Shelf Life
The shelf life is influenced by various factors including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize development of the specified tag.
Synonyms
84; Uncharacterized protein 84
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-84
Protein Length
full length protein
Species
Sulfolobus islandicus rod-shaped virus 1 (SIRV-1) (Sulfolobus virus SIRV-1)
Target Names
84
Target Protein Sequence
MNYLRRKMKMSETTLVLTIISTTTTTLFAIIQLYLKIKQALKDAVKEIVNSELSNLKTEI EELKIKQDELSRQVEEIKRKLDQK
Uniprot No.

Target Background

Database Links

KEGG: vg:951376

Subcellular Location
Host membrane; Single-pass membrane protein.

Q&A

What is Sulfolobus islandicus rod-shaped virus 1 (SIRV1) and what is known about its uncharacterized proteins?

SIRV1 belongs to the Rudiviridae family of archaeal viruses that infect the hyperthermophilic archaeon Sulfolobus islandicus in extreme environments characterized by high temperatures (70-80°C) and acidity (pH 3). Like its better-studied relative SIRV2, SIRV1 contains numerous uncharacterized proteins of unknown function. The genome architecture of these rod-shaped viruses includes a core set of approximately 30 genes that represent 50-60% of the genome, conserved across all sequenced SIRV isolates . Uncharacterized proteins, including protein 84, likely play key roles in the viral life cycle, potentially in host interaction, immune evasion, or replication mechanisms.

What sequence-based approaches can be used to begin characterizing SIRV1 protein 84?

For initial characterization of SIRV1 protein 84, implement a comprehensive bioinformatics pipeline including:

  • Sequence homology searches against protein databases using BLAST and HMM-based tools

  • Domain and motif identification using InterProScan, SMART, and Pfam

  • Secondary structure prediction using PSIPRED and JPred

  • Disordered region prediction with PONDR or DisoPred

  • Analysis of physicochemical properties using ProtParam

These computational approaches should be combined for optimal prediction accuracy. Studies on similar uncharacterized proteins have demonstrated that integrating multiple prediction methods can achieve approximately 83.6% prediction efficacy when evaluated through receiver operating characteristics analysis .

How can homology modeling assist in predicting the function of SIRV1 protein 84?

Homology modeling can provide valuable structural insights even when sequence identity is relatively low. To implement this approach:

  • Submit the protein 84 sequence to structure prediction servers such as Swiss-PDB and Phyre2

  • Select templates with maximum sequence coverage, even if sequence identity is modest (14-97% range has proven useful in similar studies)

  • Build multiple models using different algorithms and templates

  • Validate model quality using PROCHECK and other structure assessment tools

  • Analyze structural features like potential active sites, binding pockets, and electrostatic surface potential

Structural predictions can reveal functional similarities not evident from sequence analysis alone and guide experimental design. This approach has successfully assigned functions to numerous uncharacterized proteins in various microbial systems .

How might SIRV1 protein 84 relate to known nucleases in the RecB superfamily found in other rudiviruses?

Based on studies of related rudiviruses, SIRV1 protein 84 may share functional similarities with characterized nucleases like SIRV2gp19, which belongs to the RecB nuclease superfamily. SIRV2gp19 functions as a single-strand specific endonuclease requiring Mg2+ for activity and contains a conserved aspartic acid in Motif II (D89) that is essential for its activity .

To investigate potential nuclease activity in protein 84:

  • Perform sequence alignment with SIRV2gp19 and other related proteins to identify conserved catalytic motifs, particularly the RecB nuclease superfamily Motifs II (GxhD) and III (hhE/DhK)

  • Express and purify recombinant protein under native conditions

  • Conduct nuclease assays using single-stranded and double-stranded DNA substrates in the presence of various divalent cations

  • Perform site-directed mutagenesis of predicted catalytic residues to confirm their importance

If protein 84 is a nuclease, it may participate in host chromosome degradation during lytic infection, similar to SIRV2gp19 .

What role might SIRV1 protein 84 play in viral anti-defense mechanisms against archaeal CRISPR-Cas systems?

Recent research has identified several archaeal virus proteins that function as anti-defense genes (ADGs), counteracting host defense systems like CRISPR-Cas. If SIRV1 protein 84 functions as an ADG, it would likely be:

  • Expressed early in infection

  • Regulated by a conserved promoter sequence similar to those identified in SIRV2

  • Potentially clustered with other ADGs in the genome

  • Structurally similar to known anti-CRISPR (Acr) proteins or anti-CRISPR associated (Aca) proteins

To test this hypothesis:

  • Analyze the genomic context and expression timing of protein 84

  • Search for consensus regulatory sequences upstream of its coding region

  • Perform inhibition assays against purified CRISPR-Cas components, particularly Type I-A systems prevalent in Sulfolobus species

  • Test for direct interaction with CRISPR-Cas proteins using pull-down assays and surface plasmon resonance

Recent studies have identified several archaeal Acr proteins including AcrID1, AcrIIIB1, AcrIIIB2, and AcrIII-1, providing valuable reference points for comparison .

What expression systems are optimal for producing recombinant SIRV1 protein 84 for biochemical characterization?

For successful expression and purification of SIRV1 protein 84:

Expression SystemAdvantagesDisadvantagesRecommended Tags
E. coli BL21(DE3)High yield, simple cultivationPotential folding issuesHis6, MBP
E. coli RosettaAddresses rare codon biasModerate yieldHis6, SUMO
Sulfolobus expression systemsNative folding environmentComplex cultivation, lower yieldHis6
Cell-free systemsAvoids toxicity issuesExpensive, scaled-downHis6, Strep-tag

For thermostable archaeal proteins like SIRV1 protein 84, E. coli expression followed by heat treatment (70°C) often provides an effective purification step, as host proteins will denature while the thermostable target protein remains soluble. Consider fusion partners like MBP or SUMO to enhance solubility if initial expression yields are low.

What approaches can determine whether SIRV1 protein 84 interacts with host proteins or nucleic acids?

To characterize potential molecular interactions:

  • Nucleic acid binding assays:

    • Electrophoretic mobility shift assays (EMSA) with single and double-stranded DNA/RNA

    • Fluorescence anisotropy with labeled nucleic acids

    • Filter binding assays

  • Protein-protein interaction studies:

    • Co-immunoprecipitation with Sulfolobus lysates

    • Bacterial/yeast two-hybrid screening

    • Proximity labeling in vivo using BioID or APEX2

    • Surface plasmon resonance with purified host proteins

  • In vivo interaction mapping:

    • Chromatin immunoprecipitation (if DNA-binding is suspected)

    • RNA immunoprecipitation (if RNA-binding is suspected)

    • Cross-linking mass spectrometry for protein-protein interactions

When designing these experiments, consider the extreme conditions of the natural environment (pH 3, 70-80°C) and adjust experimental conditions accordingly to maintain physiological relevance .

How can high-throughput approaches be used to predict the function of SIRV1 protein 84?

Implement a multi-layered strategy combining:

  • Comparative genomics:

    • Analyze conservation patterns across rudiviruses

    • Identify syntenic regions and gene neighborhoods

    • Compare with 30 core genes shared among all SIRV isolates

  • Transcriptomics:

    • Analyze expression timing during infection

    • Look for co-expression patterns with genes of known function

    • Compare with early genes in SIRV2 that are expressed from a conserved promoter

  • Interaction networks:

    • Perform STRING analysis to predict interaction partners

    • Construct guilt-by-association networks

    • Look for clustering with other functional modules

  • Structural genomics:

    • Submit to structural prediction servers like AlphaFold

    • Compare predicted structures with functional structural databases

    • Identify potential active sites through cavity analysis

This integrated approach has successfully annotated numerous uncharacterized proteins, achieving functional assignments for 46 previously uncharacterized proteins in similar studies .

How would you determine if SIRV1 protein 84 is involved in the viral lytic cycle?

To investigate a potential role in the lytic cycle:

  • Generate a recombinant SIRV1 with protein 84 deletion or mutation

  • Compare infection dynamics between wild-type and mutant viruses by:

    • Measuring viral replication kinetics

    • Monitoring host cell lysis using microscopy and cell integrity assays

    • Quantifying progeny virus production

  • Use fluorescence microscopy to track localization during infection:

    • Create fluorescently tagged protein 84

    • Monitor localization relative to host chromosome

    • Look for association with viral assembly sites or pyramid-like structures involved in viral release

  • Assess impact on host chromosome degradation:

    • Monitor host DNA degradation patterns during infection

    • Compare with patterns observed with SIRV2gp19, a characterized nuclease

    • Perform in vitro nuclease assays with purified protein

These approaches can determine whether protein 84 functions similarly to SIRV2gp19, which participates in host chromosome degradation during lytic infection .

How can comparative genomics reveal the evolutionary history and functional constraints on SIRV1 protein 84?

Implement the following comparative genomics approaches:

  • Sequence conservation analysis:

    • Align homologs from different SIRV isolates and related rudiviruses

    • Calculate site-specific evolutionary rates

    • Identify conserved residues under purifying selection

  • Phylogenetic profiling:

    • Construct phylogenetic trees of protein 84 homologs

    • Compare with viral core genome phylogeny

    • Identify potential horizontal gene transfer events

  • Selective pressure analysis:

    • Calculate dN/dS ratios to distinguish between purifying and diversifying selection

    • Compare with patterns observed in core genes

    • Identify regions under positive selection that may interact with host factors

Current research indicates that SIRV core genes typically show evidence of purifying selection rather than diversifying selection, suggesting that variable genes govern the coevolutionary arms race between SIRVs and their hosts .

What can CRISPR spacer analysis tell us about the interactions between SIRV1 protein 84 and host defense mechanisms?

CRISPR spacer analysis can provide insights into virus-host coevolution:

  • Spacer mapping:

    • Extract CRISPR spacers from Sulfolobus islandicus genomes

    • Map spacers to SIRV1 genome, focusing on the protein 84 gene region

    • Quantify protospacer distribution and hotspots

  • Protospacer adjacent motif (PAM) analysis:

    • Identify PAM sequences associated with protein 84 protospacers

    • Compare targeting frequency with other viral genes

  • Geographical distribution:

    • Compare CRISPR targeting patterns across geographically distinct host populations

    • Correlate with viral genetic diversity from different locations

This approach leverages the "molecular memory" of CRISPR arrays to reconstruct past virus-host interactions. Studies have shown that S. islandicus genomes contain signatures of ongoing coevolutionary arms races with local viral populations, including SIRVs .

What emerging technologies could advance our understanding of SIRV1 protein 84 function?

Several cutting-edge approaches show promise for uncharacterized archaeal viral proteins:

  • Cryo-electron microscopy:

    • Determine high-resolution structures of protein 84 alone and in complex with interaction partners

    • Visualize architectural changes during viral infection

  • Single-molecule techniques:

    • Real-time observation of nuclease activity (if applicable)

    • FRET-based interaction studies

    • Optical tweezers for DNA-protein interaction dynamics

  • Mass spectrometry-based interactomics:

    • Thermal proteome profiling to identify targets

    • Cross-linking mass spectrometry for structural information

    • Hydrogen-deuterium exchange for conformational dynamics

  • High-throughput functional screening:

    • CRISPR-based screens in archaeal hosts

    • Activity-based protein profiling

    • Phage display for mapping interaction domains

These advanced technologies can overcome the limitations of traditional approaches and provide deeper insights into the molecular mechanisms of protein 84 function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.